These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17132640)

  • 1. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease (Silva MF et al. Brain 2005; 128: 2260-2271).
    Gaynes BI
    Brain; 2006 Dec; 129(Pt 12):e61; aauthor reply e62. PubMed ID: 17132640
    [No Abstract]   [Full Text] [Related]  

  • 2. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
    Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
    Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage-dependent patterns of disturbed neural synchrony in Parkinson's disease.
    Berendse HW; Stam CJ
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S440-5. PubMed ID: 18267280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
    Kish SJ
    Adv Neurol; 2003; 91():39-49. PubMed ID: 12442662
    [No Abstract]   [Full Text] [Related]  

  • 5. Vision in Parkinson's disease.
    Hutton JT; Morris JL
    Adv Neurol; 2001; 86():279-88. PubMed ID: 11553987
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathological network activity in Parkinson's disease: from neural activity and connectivity to causality?
    Timmermann L; Fink GR
    Brain; 2011 Feb; 134(Pt 2):332-4. PubMed ID: 21278405
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathophysiology of the motor cortex in patients with Parkinson's disease.
    Rothwell JC
    Adv Neurol; 1999; 80():27-9. PubMed ID: 10410699
    [No Abstract]   [Full Text] [Related]  

  • 8. Central and peripheral autonomic integrity in Parkinson's disease.
    Adhiyaman V; Hobson P; Meara RJ
    Age Ageing; 2008 Sep; 37(5):578-81. PubMed ID: 18687873
    [No Abstract]   [Full Text] [Related]  

  • 9. The globus pallidus pars externa and Parkinson's disease. Ready for prime time?
    Obeso JA; Rodriguez-Oroz MC; Javier Blesa F; Guridi J
    Exp Neurol; 2006 Nov; 202(1):1-7. PubMed ID: 16920102
    [No Abstract]   [Full Text] [Related]  

  • 10. Locomotion in Parkinson's disease: neuronal coupling of upper and lower limbs.
    Dietz V; Michel J
    Brain; 2008 Dec; 131(Pt 12):3421-31. PubMed ID: 18930965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urination disorders and parkinson disease].
    Blanchard-Dauphin A
    Rev Neurol (Paris); 2009 Feb; 165 Spec No 1():F5-10. PubMed ID: 19623702
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased cortico-cortical functional connectivity in early-stage Parkinson's disease: an MEG study.
    Stoffers D; Bosboom JL; Deijen JB; Wolters ECh; Stam CJ; Berendse HW
    Neuroimage; 2008 Jun; 41(2):212-22. PubMed ID: 18395468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug discarding: a problematic therapeutic event in Parkinson's disease.
    Miwa H; Hiwatani Y; Kondo T
    Mov Disord; 2007 Jan; 22(2):293. PubMed ID: 17083092
    [No Abstract]   [Full Text] [Related]  

  • 15. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
    Hornykiewicz O
    Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen slows Parkinson's progression.
    J Psychosoc Nurs Ment Health Serv; 1998 Aug; 36(8):11-2. PubMed ID: 9726079
    [No Abstract]   [Full Text] [Related]  

  • 18. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
    Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.
    Braak H; Del Tredici K
    Exp Neurol; 2008 Jul; 212(1):226-9. PubMed ID: 18501351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.